Alercell

Alercell, Inc. is a molecular diagnostics company that provides rapid tests for cancer and leukemia to diagnose life-threatening diseases at an early stage. The company was founded to offer more accurate and timely diagnostic tools to cancer patients worldwide. Alercell's mission is to make a difference in the fight against cancer by providing innovative and precise diagnostic solutions to improve patient outcomes. Alercell’s products are based on cutting-edge technology capable of detecting cancer and leukemia at an early stage. The company’s flagship product, the Alercell Leukemia Rapid Test, is a next-generation sequencing-based test that can detect leukemia genes within just a few hours. Healthcare professionals can use this diagnostic tool to quickly and accurately diagnose leukemia patients, enabling them to begin treatment as soon as possible.